Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-41617

Single-particle
3.12 Å
EMD-41617 Deposition: 15/08/2023
Map released: 15/11/2023
Last modified: 28/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-41617

CryoEM structure of PI3Kalpha

EMD-41617

Single-particle
3.12 Å
EMD-41617 Deposition: 15/08/2023
Map released: 15/11/2023
Last modified: 28/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: PI3Kalpha
Fitted models: 8tu6

Deposition Authors: Valverde R , Shi H, Holliday M , Sun M
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3K alpha Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia.
PUBMED: 37916956
DOI: doi:10.1158/2159-8290.CD-23-0944
ISSN: 2159-8290
Grant Support: